Nosebleed in Abilify - how severe and when it was recovered? (a real world drug study)

---

---

Severity of Nosebleed *:

• least: 0.0 %
• moderate: 71.43 %
• severe: 28.57 %
• most severe: 0.0 %

When people recovered from Nosebleed *:

• while on drug: 28.57 %
• after off the drug: 14.29 %
• not yet: 57.14 %

Effectiveness of Abilify *:

• not at all: 0.0 %
• somewhat: 0.0 %
• moderate: 42.86 %
• high: 42.86 %
• very high: 14.29 %

Race of the people *:

• African American, Non-Hispanic: 0.0 %
• American Indian/Alaska Native: 0.0 %
• Asian: 0.0 %
• Hispanic: 14.29 %
• Native Hawaiians/Pacific Islanders: 0.0 %
• Two or more races: 14.29 %
• White, Non-Hispanic: 71.43 %

Time on Abilify *:

• < 1 month: 28.57 %
• 1 - 6 months: 28.57 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 14.29 %
• 2 - 5 years: 14.29 %
• 5 - 10 years: 0.0 %
• 10+ years: 14.29 %

Gender of people when taking Abilify *:

• female: 62.5 %
• male: 37.5 %

Age of people when taking Abilify *:

• 0-1: 0.0 %
• 2-9: 25.0 %
• 10-19: 50.0 %
• 20-29: 12.5 %
• 30-39: 12.5 %
• 40-49: 0.0 %
• 50-59: 0.0 %
• 60+: 0.0 %

Conditions people have *:

1. Stress And Anxiety: 2 people, 25.00%
2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 12.50%
3. Drowsiness: 1 person, 12.50%
4. Birth Control: 1 person, 12.50%
5. Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 1 person, 12.50%
6. Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 1 person, 12.50%
7. Atypical Attention Deficit Syndrome (childhood psychiatric disorder-distractibility, impulsiveness, and hyperactivity): 1 person, 12.50%
8. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 12.50%
9. Allergies: 1 person, 12.50%
10. Adolescent Depression: 1 person, 12.50%

Other drugs people take besides Abilify *:

1. Claritin: 2 people, 25.00%
2. Zoloft: 1 person, 12.50%
3. Yaz: 1 person, 12.50%
4. Trintellix: 1 person, 12.50%
5. Trazodone Hydrochloride: 1 person, 12.50%
6. Sulfasalazine: 1 person, 12.50%
7. Methotrexate: 1 person, 12.50%
8. Lo Loestrin Fe: 1 person, 12.50%
9. Lithium Carbonate: 1 person, 12.50%
10. Klonopin: 1 person, 12.50%

Other side effects people have besides Nosebleed *:

1. Swollen Glands (swelling of gland): 1 person, 12.50%
2. Red Blood Cell Sedimentation Rate Increased: 1 person, 12.50%
3. Rashes (redness): 1 person, 12.50%
4. Platelet Count Increased: 1 person, 12.50%
5. Headache (pain in head): 1 person, 12.50%
6. Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 1 person, 12.50%
7. Encephalopathy (functioning of the brain is affected by some agent or condition): 1 person, 12.50%
8. Dark Circles Under Eyes: 1 person, 12.50%
9. Confusion: 1 person, 12.50%
10. Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 1 person, 12.50%

Do you take Abilify and have Nosebleed?

Check whether Nosebleed is associated with a drug or a condition

---